Our Vision
Our vision is that our technology will enable low-dose 3D X-ray imaging to be cheaper, more widely available and truly portable throughout the world’s clinics and hospitals.

This is of value to Patient, Physician and Payer, by replacing 2D imaging with more accurate 3D imaging, and allowing that more accurate diagnosis to be at the Point-of-Care, reducing the need to move patients or refer to 3D imaging.

Clinicians (End-User)
For clinicians, our innovative technology provides wide-ranging benefits, from low-cost, low-dose, truly portable 3D imaging, to image acquisition within 5 seconds with image reconstruction in less than 60 seconds;

3D at the bedside / chairside in the treatment room
Fixed DT can avoid 70-80% of escalation to CT (chest imaging) and dramatically reduced patient dose, bring that to the bedside could transform patient care
Enhanced sensitivity versus 2D
Reduced false negatives versus 2D
Reduced patient dose on a population basis

Industry

New offer: Portable 3D to replace portable 2D
Digital Tomosynthesis (‘DT’) disrupted the breast imaging market, with the early adopter (Hologic) seizing a dominance that lasts even after competitors have achieved technological parity. DT is now entering the fixed radiology market (GE, AGFA, Shimadzu, FujiFilm) but it is imaging at the bedside that could be the next disruption
Defend against low-cost Asian competition in 2D market (where patents have expired)
Buy-in to an onward pathway of innovation – next stop … colour imaging

Completing the digitisation of X-ray imaging to allow truly portable low-dose 3D imaging
Completing the digitisation of the system allows ‘Digital Tomosynthesis’ (‘DT’) – low dose 3D imaging – with no moving parts. DT, in the context of fixed systems, has transformed Breast Imaging and shown an ability to materially reduce the need to escalate patients to CT.

Our FPS allows DT systems to be truly portable and low cost – freeing 3D imaging to be deployed at the bed- or chair-side, and one day in ambulances. In summary, we allow truly portable low-dose low-cost 3D to be taken to the Point-of-Care and avoiding the need to take the patient to radiology.

Research and Development Services

Servcies Overview